ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

LYTE: Living Your Truth Empowered

July 23, 2024

LYTE is a non-profit organization that aims to meet the needs of a growing and diverse breast cancer survivor community by providing expert health and wellness coaching.

LYTE: Living Your Truth Empowered

Twenty-two hours after she was born, Jessica Clague DeHart, PhD, was on an airplane from Boise, Idaho to Southern California in the arms of her adopted parents. An ovarian cancer diagnosis left her adopted mother unable to conceive. “I was due on Christmas [day] and came early so my adopted parents were called and told they had to get to Boise, because I was on my way, and I had to be out of the state before I was 24 hours old.”

“I really feel like cancer is a part of my identity.”

Dr. Clague DeHart’s adoptive parents are theatre majors who met in London. “They say they always knew I was adopted because I loved science and would do experiments when I was younger,” she said. “But I was also a professional ballerina.”

Her career as a ballerina ended abruptly following a major knee injury during the opening night of a solo performance. “There was a USC [University of Southern California] orthopedic surgeon in the audience who saw me backstage and said he didn’t think I would be dancing for a while,” Dr. Clague DeHart said. At the same time, her grandfather was undergoing treatment for pancreatic cancer at the USC Norris Comprehensive Cancer Center. “Because I couldn’t go to dance rehearsal, I volunteered to take him,” she shared. “I annoyed the heck out of the oncologists with all my questions about how and why he got cancer, so they encouraged me to consider going to school for medicine.”

That experienced nurtured a curiosity Dr. Clague DeHart always harbored. She applied and was accepted to USC as a pre-medicine student with a minor in dance; her essay detailed her vision of working in a laboratory in ballet shoes. “At USC, I learned about public health and epidemiology and how there was more to studying disease than treatment,” she said. “So, I switched majors to join one of the country’s first undergrad[uate] programs in health promotion and disease prevention.”

Cancer Prevention

For Dr. Clague DeHart, it was not enough to simply treat diseases, the goal was to prevent them. “My grandfather did end up passing. I was in the room with him, and he said, “You got to beat this thing.” So, cancer has always been at the core of what I do. Anytime I have gone off path, something else brings me back to it.”

To understand and ultimately prevent cancer, Dr. Clague DeHart realized the necessity of overcoming the monotony that has dictated oncology research in the past, where the focus on developing solutions often fails to consider the communities they will be implemented in. “We have brilliant, fantastic interventions that we come up with as scientists and they work, but if people are not doing them, then what’s the point,” she explained. So, she spent the next 2 decades entrenched in breast cancer research, conducting intervention trials and working to develop strategies to reduce the mortality and reoccurrence rates of the disease. Then in 2016, while she was an assistant professor at City of Hope Cancer Center, her adopted mother was diagnosed with late-stage, triple-negative breast cancer.

According to Dr. Clague DeHart, her adopted mother delayed seeking medical attention for the lump in her breast due to the trauma of her ovarian cancer diagnosis. “My mom had so much PTSD [Post-traumatic stress disorder] from her ovarian cancer that she refused to go to the doctor,” Dr. Clague DeHart shared. “And it hit me that no matter what cancer, there’s this true PTSD that happens, a lot of people ring the bell and then they’re done—then it’s silence.”

“My research became all too real as I spent the next 2 years attending every treatment and appointment and seeing the aftermath of treatment and symptoms at home.”

Her final day of treatment came, and the bell rang once more, but as the path to survivorship beckoned, the requisite resources to ensure success were not provided. “The physical and psychological collateral damage of successful cancer treatment is often overwhelming, and I learned from talking to hundreds of other breast cancer survivors that this was not unique to my mom’s experience,” Dr. Clague DeHart said. “In fact, when that celebratory bell falls silent and the pink confetti is swept up, there are over 4 million breast cancer survivors facing their new normal and they are left asking, ‘Now what?’”

“It became very clear to me that something needed to be done and it would need to be community-based.”

Armed with this perspective, Dr. Clague DeHart founded LYTE: Living Your Truth Empowered in August 2022. “LYTE’s mission is to meet the needs of a growing and diverse breast cancer survivor community—regardless of any social drivers of health or stage at diagnosis—by providing no-cost, community-based, locally and culturally tailored charters, run by expertly trained health and wellness coaches,” she explained. “We provide no-cost NBHWC [National Board for Health and Wellness Coaching] credential training to breast cancer advocates and community members who agree to coach breast cancer survivors.”

“I love ACCC [Association of Cancer Care Centers] because it is about the community. That is where we need to be in survivorship, outside of the confines of cancer centers.”

The 16-week training program graduated its first cohort of coaches this May and Dr. Clague DeHart is excited for what the future holds. “We believe engaging in equitable storytelling creates a partnership rather than a simple exchange of information; bringing forward stories that shatter stigma and uplift marginalized voices,” she said. “Therefore, we are also launching an equity-based storytelling program that incorporates advocacy and the arts among breast cancer survivors and a few other research studies.”

LYTE Partnerships + Charters

For cancer programs and practices looking for ways to improve their breast cancer survivorship program, Dr. Clague DeHart believes LYTE could be the answer. “The first thing would be for [these organizations] to have a conversation with our team to see how we can help,” she explained. “Some organizations want the health coaching model, but a small cancer center could send patients to us for health coaching immediately after treatment.”

For communities interested in LYTE charters, the foundation provides training and rigorous needs assessments to ensure the correct standards are met and upheld. “This includes grant writing for LYTE charters in need of sustainable funding,” Dr. Clague DeHart said. “We offer a lot of services, but it all depends on what the community needs, and it always starts with a conversation.”

Dr. Clague DeHart remains fervent in her goal of preventing cancer, but that mission now includes changing the survivorship landscape of the disease; this includes patients living with metastatic breast cancer. "I had a conversation with a few advocates, and they said, 'LYTE is awesome, but just like everyone else, you have forgotten about us.' So, we now include those living with MBC [metastatic breast cancer] in the definition of survivors," she said.

The larger goal that continues to drive Dr. Clague DeHart is for every single breast cancer survivor—eventually every cancer survivor—to be met by a LYTE representative on their last day of treatment who "congratulates them and invites them for a conversation about the rest of their life."

"So, there is never that silence."

Related Content

Extending Patient-Centered Cancer Care to Transgender and Nonbinary IndividualsACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Gabrielle Stearns

June 30, 2026

Transforming Oncology Authorization Through Clinical and Revenue Cycle CollaborationACCCBuzz Blog

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Rachel Radwan

June 29, 2026

Building a Blueprint for Precision Medicine: Lessons from TriHealthACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

June 25, 2026

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

Building a Blueprint for Precision Medicine: Lessons from TriHealth

Building a Blueprint for Precision Medicine: Lessons from TriHealth

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

MDS: Low Risk Isn’t No Risk - [Podcast] Ep. 239

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing - [Podcast] Ep. 238

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 237

Championing Bispecific Antibodies in the VA - [Podcast] Ep. 236

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login